Since ARBs block the biologic effects of angiotensin II more completely than ACE inhibitors, they could be beneficial in the treatment of heart failure. In a direct comparison trial (ELITE-II ...

Considerations of drug type, specific drugs ... As previously mentioned, ARBs may offer some advantage compared with ACE inhibitors in CHF patients prone to hyperkalemia, although this hypothesis ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

Instead, a different type of medication called thiazide diuretics may work better and cause fewer side effects. Doctors have ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...